Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions
<b>Background/Objectives:</b> Non-small-cell lung cancer (NSCLC) remains a leading cause of cancer mortality globally, though advances in targeted therapies have improved treatment outcomes. The mesenchymal–epithelial transition (<i>MET</i>) gene plays a significant role in N...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Antibodies |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4468/13/4/88 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|